- Home
- BOLT vs GIGM Comparison
BOLT vs GIGM Comparison
Compare BOLT & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- GIGM
- Stock Information
- Founded
- BOLT 2015
- GIGM 1998
- Country
- BOLT United States
- GIGM Taiwan
- Employees
- BOLT N/A
- GIGM N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- BOLT Health Care
- GIGM Technology
- Exchange
- BOLT Nasdaq
- GIGM Nasdaq
- Market Cap
- BOLT 16.8M
- GIGM 17.9M
- IPO Year
- BOLT 2021
- GIGM 2000
- Fundamental
- Price
- BOLT $5.91
- GIGM $1.45
- Analyst Decision
- BOLT Buy
- GIGM
- Analyst Count
- BOLT 3
- GIGM 0
- Target Price
- BOLT $50.00
- GIGM N/A
- AVG Volume (30 Days)
- BOLT 26.0K
- GIGM 29.7K
- Earning Date
- BOLT 08-12-2025
- GIGM 07-30-2025
- Dividend Yield
- BOLT N/A
- GIGM N/A
- EPS Growth
- BOLT N/A
- GIGM N/A
- EPS
- BOLT N/A
- GIGM N/A
- Revenue
- BOLT $3,638,000.00
- GIGM $3,103,000.00
- Revenue This Year
- BOLT N/A
- GIGM N/A
- Revenue Next Year
- BOLT $24.14
- GIGM N/A
- P/E Ratio
- BOLT N/A
- GIGM N/A
- Revenue Growth
- BOLT N/A
- GIGM N/A
- 52 Week Low
- BOLT $5.20
- GIGM $1.26
- 52 Week High
- BOLT $15.60
- GIGM $1.80
- Technical
- Relative Strength Index (RSI)
- BOLT 47.01
- GIGM 50.64
- Support Level
- BOLT $5.52
- GIGM $1.41
- Resistance Level
- BOLT $6.21
- GIGM $1.45
- Average True Range (ATR)
- BOLT 0.33
- GIGM 0.05
- MACD
- BOLT 0.04
- GIGM 0.00
- Stochastic Oscillator
- BOLT 48.67
- GIGM 25.00
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.